Privacy Notice - Notice of Personal Data Processing

Novo Nordisk Pharmaceuticals (Philippines), Inc.
21F Twenty-Four Seven Mckinley Building, 24^th Street corner 7^th Avenue, Bonifacio Global City, Fort Bonifacio, Taguig City, Philippines
E-mail: NNPPISafety@novonordisk.com
Phone: +632 8234 3590

You can always contact Novo Nordisk Philippines or the Novo Nordisk Data Privacy Officer at privacyph@novonordisk.com with questions or concerns about how we process your personal data.

From you directly
From your family members or care givers on your behalf
From Health Care Professionals such as your nurse, a pharmacist or doctor
Through phone calls, emails and other digital channels

To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products. Complaints and side effects will be filed in databases and will be regularly analysed for overall patterns.
To respond to your questions or request for information
To analyse data for the purpose of supporting product usage enquiries
To analyse data for the purpose of improving our customer service and product offerings
To analyse data for the purpose of improve our scientific and product communication to HCPs and patients
To assess patterns and trends associated with complaints, side effect and product usage

Contact information (name, address, telephone number, email address);
Data revealing racial or ethnic origin;
Data concerning health and medicinal products you are using;

The processing is necessary for our legitimate interests. The legitimate interests are:

a. The processing is necessary for our compliance with a legal obligation

b. To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products.

c. To improve our customer service and product offerings

d. To enhance our scientific and product communication

e. You gave consent for us to process your personal data

Suppliers or vendors that assist our company (e.g., consultants, IT service providers, financial institutions, law firms, license partners)
Other Novo Nordisk entities (e.g., Novo Nordisk affiliates in other countries)
Public authorities, including health and/or regulatory authorities
Other pharma companies and partners if an enquiry is related to their product(s)

We have safeguards in place to secure your personal data when transferred outside of the European Economic Area (EEA).

Situation

Safeguards protecting your data

Data is transferred from Novo Nordisk entity in EEA to Novo Nordisk entity outside EEA

Protected by Novo Nordisk’s Binding Corporate Rules, available at https://www.novonordisk.com/content/dam/nncorp/global/en/data-privacy/novo-nordisk-binding-corporate-rules.pdf

Data is transferred from Novo Nordisk entity in EEA to third country

Protected by Standard Contractual Clauses for the transfers of data to third countries entered into by Novo Nordisk.

Or, adequate data protection is in place in destination country according to EU commission

For data relating to technical complaints: 12 years
For safety information and data relating to side effects: End of activity + 10 years, where end of activity is the time where no product with the active ingredient is marketed
For all other enquiries: Up to 5 years

Your rights	How you exercise your rights
Overview of your data	Ask for a copy of your personal data, which we provide in a structured format, readable to a machine
Restrict use	Request that we stop or limit the use of your personal data
Deletion	Request that your personal data is anonymised
Correct your data	Ask us to correct information about you
Complain about our use of the data	Submit a complaint to your local Data Protection Authority

Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us as described in Section 1 with questions or requests relating to these rights.